|
|
|
|
|
Detail |
| hsa-miR-9 |
|
Unspecified |
MicroRNA signatures in human ovarian cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. |
2006 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. |
2007 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. |
2007 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. |
2006 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. |
2008 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. |
2008 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Causal |
Potential role of miR-9 and miR-223 in recurrent ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Causal |
MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. |
2009 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Causal |
MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. |
2009 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. |
2008 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Causal |
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. |
2008 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Causal |
MicroRNA profiling in human medulloblastoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Causal |
The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. |
2009 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis. |
2009 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|